Atlas Trials

Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Clinical trial NCT06155331 · COMPLETED

Trial details

NCT number
NCT06155331
Sponsor
Tanta University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer Stage 2 and 3
Start date
2023-12-01
Primary completion
2025-01-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.